Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

CUSIP: 87990A106

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
-2,092,302
Put/Call ratio
298%
SEC-reported price per share
$2.85
Indexed holders
65
Value change
-$2,290,501
Number of buys
40
Open additional details 1 more signal available
Number of sells
27
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
228,303,514

Security key

87990A106

Report period

Q1 2023

Indexed institutions

65

Top holders

10

Ownership snapshot

Top reported holders of TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Casdin Partners Master Fu...
Disclosed value leader
Eli Casdin
Comparable rows
0/15
Latest evidence
31 Dec 2022
3/4/5 13F Highest disclosed value: $25,895,944 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Eli Casdin has the largest disclosed position value at $25.9M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Eli Casdin's linked filing trail.
Disclosed position value Top 5
Casdin Partners Master Fund, L.P. $1.54M
Eli Casdin $25.9M
Column Group LLC $18.89M
Casdin Capital, LLC $12.22M
RA CAPITAL MANAGEMENT, L.P. $12.2M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Casdin Partners Master Fund, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$1,541,988
361,969 shares
— 03 Aug 2021
Eli Casdin
3/4/5
Director
—
mixed-class rows
$25,895,944
7,472,698 shares
mixed-class rows
— 17 Nov 2022
Column Group LLC
13F
Company
13F
—
denominator unverified
$18,894,583
9,400,290 shares
— 31 Dec 2022
Casdin Capital, LLC
13F
Company
13F
—
denominator unverified
$12,218,509
6,078,860 shares
— 31 Dec 2022
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$12,195,641
6,067,483 shares
— 31 Dec 2022
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$8,989,000
4,472,202 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
65
Shares
45,028,141
Indexed holders
65
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 indexed holders
67
Q1 2023 indexed holders
65
Indexed holder difference
-2
Investor Q4 2022 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2022 value Q1 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .